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Background. Mixed findings in biobehavioral research on heart disease may partly be attributed to age-related differences in the
prognostic value of psychological distress. This study sought to test the hypothesis that Type D (distressed) personality contributes
to an increased mortality risk following implantable cardioverter defibrillator (ICD) treatment in younger patients but not in older
patients. Methods. The Type D Scale (DS14) was used to assess general psychological distress in 455 younger (≤70 y, 𝑚 = 59.1)
and 134 older (>70 y, 𝑚 = 74.3) ICD patients. End points were all-cause mortality and cardiac death after a median follow-up of
3.2 years. Results. Older patients had more advanced heart failure and a higher mortality rate (𝑛 = 34/25%) than younger patients
(𝑛 = 60/13%), 𝑃 = 0.001. Cardiac resynchronization therapy (CRT), but not Type D personality, was associated with increased
mortality in older patients. Among younger patients, however, Type D personality was associated with an adjusted hazard ratio =
1.91 (95% CI 1.09–3.34) and 2.26 (95% CI 1.16–4.41) for all-cause and cardiac mortality; other predictors were increasing age, CRT,
appropriate shocks, ACE-inhibitors, and smoking.Conclusion. Type D personality was independently associated with all-cause and
cardiac mortality in younger ICD patients but not in older patients. Cardiovascular research needs to further explore age-related
differences in psychosocial risk.
1. Introduction
Beyond the age of 70 years, the risk of progressive heart
failure [1, 2] and mortality [2, 3] sharply increases in cardiac
patients. Age-related biological changes, such as decreased
cardiomyocyte renewal capacity and increased cardiac dys-
function, contribute to poor health in older cardiac patients
[1]. There are also important age-related differences in the
clinical profile and outcome of patients who are at risk for life-
threatening cardiac arrhythmias [4–8]. Today, implantable
cardioverter defibrillator (ICD) therapy is the first-line treat-
ment for the prevention of sudden cardiac death in these
patients [9]. When a significant arrhythmia is detected, the
ICD restores a normal heart rhythm by providing antitachy-
cardia pacing or, eventually, a shock. However, advanced
heart failure [4–6] and comorbid conditions [4, 5, 7] are
common in older patients and may attenuate the survival
benefit of ICD treatment [4].
Psychological distress has been associated with a higher
risk of ventricular arrhythmias and mortality in some [10–
12] but not all [13, 14] studies of ICD patients, suggesting that
other variables may moderate this association. For example,
differences in the nature and timing of depression have
also contributed to mixed findings on depression and heart
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disease [15]. To resolve the uncertainty about a causal link
between mind and heart [16], we need to identify factors
that contribute to mixed findings on psychological distress in
cardiac patients. Critically, these mixed findings may partly
be attributed to age-related differences in distress.
The influence of psychological distress on cardiovascular
outcomes may be more potent in younger than in older
patients [17–19]. Psychological distress is particularly pro-
nounced in younger ICD patients [20, 21] and may induce
changes in the autonomous nervous system that have been
implicated in the onset of ventricular arrhythmia [22–26].
Type D (distressed) personality is a propensity to general
distress (i.e., the combination of negative affectivity and
social inhibition) that may also contribute to cardiovascular
outcomes [27, 28], including poor health [29] and decreased
survival [30, 31] in patientswith an ICD.However, TypeDwas
not associated with prognosis in patients with heart failure
[32] and little is known about age-related differences in the
effect of Type D among patients with cardiac arrhythmia.
The development of novel risk stratification strategies
is needed to improve outcomes in patients with an ICD
[9], and a scientific statement from the American Heart
Association concluded that psychosocial factors such as Type
D personality may be involved in clinical events following
ICD treatment [33]. Previously, we reported that Type D and
device shocks were associated with an increased mortality
risk in a cohort study of 589 ICD patients [31]. Yet, cardiac
disease is a complex condition, and a better understanding of
the associations between distress and prognosis also involves
subgroup analyses [34] that reveal at what ages or in what
clinical subgroups such associations hold [19, 35]. Others
have used 70 years as split-point to examine the outcome
of ICD treatment in different age subgroups [7] and we
showed that depression predicted poor prognosis in cardiac
patients younger than 70 years but not in older patients
[18]. Regarding clinical subgroups, little is known about the
combined effect of shocks and psychological distress on the
outcome of ICD treatment.
Therefore, we examined the age-dependent role of shocks
and Type D personality and tested the hypothesis that Type
D personality contributes to an increased mortality risk in
younger ICD patients in particular. In addition, we explored
whether the combination of shocks and Type D personality
would involve an increase in risk among younger patients.
2. Methods
2.1. Patient Sample. This study reports on preplanned anal-
ysis of age-related differences in an observational study of
psychosocial stress among 589 patients living with an ICD
because of a high risk of life-threatening cardiac arrhythmia.
Details of this study have been described elsewhere [31].
Patients all had a first ICD implanted in the AmphiaHospital,
Breda, or Catharina Hospital, Eindhoven, The Netherlands,
between May 2003 and February 2009. The age ranged from
18 to 80 years; patients with cognitive impairment (e.g.,
dementia) and psychiatric disorders other than affective dis-
order were excluded.The study was conducted in accordance
with the Helsinki Declaration, and all patients provided
written informed consent. The study was approved by the
Medical Ethics Committees of both participating hospitals.
2.2. Type D Personality. In order to assess TypeD personality,
all patients completed the 14-item Type D Scale (DS14)
[36] at the time of implantation [31]. Type D refers to
the combination of the tendency to experience negative
emotions (negative affectivity) and the tendency to inhibit
self-expression in social interaction (social inhibition) that
has been associated with an increased vulnerability for psy-
chological distress and poor cardiovascular outcomes [27].
The 7-item negative affectivity and social inhibition subscales
of the DS14 are internally consistent (Cronbach’s 𝛼 = 0.88
and 0.86) and stable over time [36]. Patients scoring above
the standardized cut-off ≥10 on both subscales are classified
as having a Type D personality.
2.3. Younger versus Older Age. To examine the age-related
differences in clinical profile, survival, and prognostic mark-
ers, patients were stratified by age into younger and older age
groups. In analogy with previous ICD research, patients aged
≤70 years were considered to be relatively younger compared
to patients aged >70 years [7]. In addition, previous research
on Type D personality [27] largely focused on relatively
younger patients aged <70 years or <75 years, with the mean
age ranging between 55 and 57 years.Hence,≤70 yearwas also
used as a cut-off in the present study to test the hypothesis
that the tendency to experience psychological distress might
primarily contribute to poor survival in younger rather than
older patients [18, 19].
2.4. Endpoints. The first endpoint was all-cause death.
Because some patients do not benefit from ICD therapy
because of competing noncardiac death risks [9], we also
examined the association of Type D with cardiac death as a
more rigorous endpoint of cardiac prognosis. As discussed
previously, the endpoints in this study were derived from the
medical records, and the cause of death was discussed with
the treating cardiologist or general practitioner [31].
2.5. Shocks and Other Statistical Covariates. Device shocks
have been related to an increased mortality risk in patients
with an ICD [4, 5] and were included in all multivariable
analyses. Electrophysiologists judged the nature of shocks
on the basis of device interrogation; ICD shocks were
considered to be inappropriate if they were triggered by
abnormal sensing or by nonventricular arrhythmias and to be
appropriate if they were triggered by ventricular tachycardia
or by ventricular fibrillation. Some patients were treated with
the combination of an ICD with cardiac resynchronization
therapy (CRT-D); because CRT-D further improves the
clinical course of heart failure [37], we controlled for this
treatment variable in multivariable models. Other statistical
covariates included left ventricular ejection fraction (LVEF)
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Figure 1: Association of Type D personality with all-cause mortality in older (a) and younger (b) ICD patients.
≤35%, primary versus secondary indication for ICD treat-
ment, coronary artery disease (CAD), beta-blockers, ACE-
inhibitors, diabetes mellitus, smoking, gender, and marital
status (having a partner versus having no partner).
2.6. Statistical Analyses. Clinical characteristics of the sample
stratified by age were examined with chi-square tests for
categorical variables and 𝑡-tests for independent samples for
continuous variables. Multivariable Cox regression analyses
were used to examine the hypothesis that Type D may play
an independent prognostic role in younger ICD patients
(≤70 years). Separate multivariable regression models were
construed for both all-cause and cardiac-related death. A chi-
square test was used to explore the combined effect of shocks
and Type D personality in younger patients. All tests were
two-tailed and a𝑃 value < 0.05 was used to indicate statistical
significance. All analyses were performed in PASW Statistics
17 for Windows.
3. Results
3.1. Clinical Characteristics of Younger versus Older Patients.
Themean age of the ICD patients was 62.6 years; 455 patients
were aged ≤70 years and 134 aged >70, with the first subgroup
being on average 15 years younger than the second subgroup
(59 versus 74 years). This stratification by age revealed a
different clinical profile; that is, older patients were more
likely to have advanced heart failure, as indicated by a higher
prevalence of left ventricular dysfunction andCRT treatment,
than younger patients (Table 1). After a median follow-up of
3.2 (range 0.8–6.5) years, there were 94 (16%) ICD patients
who had died from all causes and 67 (11%) patients who
had died from cardiac causes [31]. The rate of both all-cause
death and cardiac death was approximately 2 times higher
in older ICD patients compared with younger ICD patients
(𝑃 ≤ 0.003; Table 1). The mean age at the time of death was
77 years in older patients and 64 years in younger patients.
3.2. Prognosis in Older versus Younger Patients. To examine
the age-dependent importance of prognostic markers and
to test the hypothesis that psychological distress contributes
to the incidence of death in younger ICD patients, we
analyzed the predictors of mortality separately in older and
younger patients. Among older patients (>70 years), Type D
personality was not associated with mortality (Figure 1(a)).
CRT was the only independent predictor of all-cause mor-
tality in older patients (HR = 2.51, 95% CI 1.05–5.97, 𝑃 =
0.038); there was also a trend for diabetes (HR = 2.14,
95% CI 0.95–4.81, 𝑃 = 0.06) but neither for appropriate
shocks (𝑃 = 0.42) nor other covariates (𝑃 > 0.10).
Among younger ICD patients (≤70 years), Type D per-
sonality was associated with an increased risk of death from
all causes (Figure 1(b)). Type D patients had an adjusted
HR = 1.91 (95% CI 1.09–3.34) for all-cause mortality; other
significant predictors were increasing age, CRT, appropriate
shocks, (lack of) ACE-inhibitors, and smoking (Table 2).
3.3. TypeDPersonality andCardiacDeath in Younger Patients.
Given the cardiovascular effects of distress [10, 11, 25, 26],
cardiac death was included as a second endpoint in this
study. Type D personality was associated with an increased
risk of cardiac death in younger ICD patients (Figure 2). In
a multivariable Cox regression model, Type D personality
was retained as an independent predictor of cardiac death
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Table 1: Characteristics of study population, stratified by age ≤/> 70 years.
Characteristics Age ≤ 70 Age > 70 P value
𝑁 = 455 𝑁 = 134
Demographic
Age (years; mean ± SD) 59.1 ± 8.9 74.3 ± 2.5 0.0001
No partner 11% (49) 22% (29) 0.001
Male gender 81% (368) 81% (108) 0.94
Personality
Type D personality 23% (105) 22% (29) 0.73
Mortality
All-cause death 13% (60) 25% (34) 0.001
Cardiac death 9% (42) 19% (25) 0.003
ICD treatment
LVEF ≤ 35% 80% (364) 92% (123) 0.002
CRT therapy 26% (120) 41% (55) 0.001
Primary indication ICD 63% (289) 67% (90) 0.44
Appropriate shocks FU 10% (47) 10% (14) 0.97
Inappropriate shocks FU 4% (20) 6% (8) 0.45
Medical covariates
Diagnosis of CAD 71% (325) 77% (103) 0.21
Beta-blocker therapy 82% (375) 79% (106) 0.38
ACE-inhibitor therapy 67% (306) 70% (94) 0.53
Diabetes 18% (82) 22% (29) 0.35
Smoking 20% (89) 13% (17) 0.07
CAD: coronary artery disease; CRT: cardiac resynchronization therapy; LVEF: left ventricular ejection fraction; SD: standard deviation.
Table 2: Independent predictors of death from all causes in ICD
patients aged ≤70.∗
HR (95% CI) P value
Predictor variables
Type D personality 1.91 (1.09–3.34) 0.024
Age (years) 1.06 (1.02–1.10) 0.008
CRT 1.78 (0.99–3.27) 0.056
Appropriate shocks 3.50 (1.79–6.82) 0.0001
ACE-inhibitors 0.51 (0.30–0.87) 0.014
Smoking 1.85 (1.01–3.40) 0.049
∗Values were calculated with the use of multivariable Cox regression analy-
sis, including the nonsignificant covariates (gender, inappropriate shocks, left
ventricular ejection fraction, secondary indication, coronary artery disease,
beta-blockers, diabetes, and partner status).
CI: confidence interval; CRT: cardiac resynchronization therapy; HR: hazard
ratio.
in younger ICD patients (HR = 2.26, 95% CI 1.16–4.41, 𝑃 =
0.017), after adjustment for CRT (HR = 3.08, 95% CI 1.53–
6.22, 𝑃 = 0.002) and appropriate shocks (HR = 3.95, 95%CI
1.75–8.91, 𝑃 = 0.001). There was also a trend for increasing
age (𝑃 = 0.06) and smoking (𝑃 = 0.053) in these patients.
Finally, cardiac death was examined in 4 groups of
younger patients, stratified by Type D and shocks (Figure 3).
Patients with Type D or shocks only had a similar risk of
cardiac death. Risk of cardiac death was highest in Type D
patients who received a shock (36%), followed by patients
with one riskmarker only (12%); patients with nomarker had
the lowest risk.
4. Discussion
ICD shocks have been related to an increased mortality
risk [4, 5], but a scientific statement from the American
Heart Association also highlighted the need to improve the
identification and care of psychosocial factors, such as Type
D personality, in patients with an ICD [33]. We previously
reported that Type D may have detrimental consequences
for the outcome of ICD treatment in this cohort of patients
with life-threatening cardiac arrhythmias [31] and that Type
Dpersonalitymay be associatedwith ventricular arrhythmias
in ICD patients [38]. Previous research in another cohort
of patients with an ICD also showed that Type D was
significantly associated with an increased risk of emotional
distress [29] and mortality [30].
However, patients who are older already have an
increased mortality risk due to biological aging of the car-
diovascular and other organic systems [1–3], which limits
the incremental prognostic value of psychosocial distress.
Accordingly, the present analyses showed that Type D per-
sonality was associated with mortality in younger but not
older ICD patients. Age-related differences in prognosis
may result from different mechanisms of disease. Among
older patients, CRT and diabetes, but not shocks or Type
D, were associated with mortality. Evidence suggests that
age-related biological changes may contribute to adverse
BioMed Research International 5
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Figure 2: Cardiac survival of younger ICD patients (𝑁 = 455),
stratified by Type D personality. Cardiac death (𝑁 = 42) coded
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Figure 3: Percentage of younger ICD patients who died of cardiac
causes (𝑁 = 42), stratified by appropriate shocks and Type D
personality. NS = not significant; other groups are significantly
different fromeach other. Shocks (−) = no appropriate shocks during
follow-up; Shocks (+) = one or more appropriate shocks during
follow-up; Type D (−) = no Type D personality; Type D (+) = Type
D personality. Number of patients who died of cardiac causes and
total number of patients within each risk subgroup are presented on
top of each bar.
clinical outcomes [1, 6]. Cardiac dysfunction is particularly
pronounced in older patients due to decreased cardiomyocyte
renewal capacity and increased apoptosis [1]. In addition,
progressive heart failure is a common cause of death in ICD
patients aged >70 years [4–6]. In this ICD cohort, older
patients were also more likely to have a CRT-D and left
ventricular dysfunction than younger patients, which may
partly explain their increased mortality risk.
In our ICD cohort, shocks and Type D personality
were associated with all-cause and cardiac death in younger
patients. Although younger ICDpatients had a better survival
rate than older patients, a substantial number of younger
patients had a poor prognosis. The mean age at the time
of death was 64 years in the 60 younger patients who died
(and 77 years in the 34 older nonsurvivors), which highlights
the high-risk profile of this subgroup. Chronic psychological
distress may explain why some younger patients were at an
increased risk of premature death. This age-dependent effect
of distress may reflect selective survival [17]; that is, Type D
patients who die at an earlier age may be more vulnerable
to stress-related cardiac dysfunction and arrhythmia as com-
pared to Type D patients who survive to old age.
The adverse effects of TypeD in younger patientsmight be
explained by the consequences of chronic psychosocial dis-
tress [27]. These may include direct biological consequences.
Among other things, Type D personality has been associated
with an increased prevalence of ventricular arrhythmia in
healthy individuals [39] and in patients with an ICD [38]
and with decreased heart rate recovery after exercise in
patients with chronic heart failure [40]. There also may be
indirect behavioral consequences that have an adverse effect
on health. For example, Type D has been related to poor
adherence to continuous positive airway pressure therapy in
patientswith obstructive sleep apnea [41], which, in turn,may
cause disturbed cardiac repolarization that can induce cardiac
arrhythmias in these patients [42].These explanations are still
hypothetical, but further research is warranted to examine
whether these pathways of disease associated with Type D
personality are age-dependent.
This study has a number of limitations [31]. First, we
did not have information on changes in disease severity
that may have occurred during follow-up. Second, 35% of
patients with CRT had a poor LVEF compared to only 2%
of patients without CRT (𝑃 < 0.001). This overlap in
clinical covariates may explain why CRT, but not LVEF, was
an independent predictor of mortality in the multivariable
regression model. Third, other markers of disease severity or
somatic comorbidity that were not included may also have
affected survival. Fourth, more research is needed to examine
clinical implications. Initial evidence suggests that age might
moderate the effect of behavioral intervention: two trials
found that younger ICDpatients aremore likely to improve in
psychological distress than older patients [43, 44]. This may
also apply to modification of emotion regulation strategies
in Type D patients [45]. Strengths of this study are the
large sample of patients who are at high risk of arrhythmia,
the prospective design of the study, and the standardized
assessment of Type D personality.
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Using Type D personality and ICD treatment of life-
threatening arrhythmias as a paradigm, the present study
highlights the importance of age-dependent differences in
psychosocial risk. Other reports also showed that the link
between heart disease and hostility or depression was more
pronounced in young individuals [17, 18]. Consistent with
these reports, we observed that younger ICD patients may
have an increased mortality risk due to psychosocial distress.
In this age group, the risk of cardiac death was the highest
in Type D patients who received a shock. Hence, these
findings indicate that clinical subgroup analyses may further
improve our understanding of the associations between
psychosocial distress and prognosis [34, 35]. However, the
prognostic value of distress in older patients is limited due
to cardiovascular and biological aging. In our study, cardiac
resynchronization therapy, ventricular systolic dysfunction,
and diabetes were more common and predicted mortality in
older ICDpatients. In conclusion, health professionals should
be aware of age-related individual differences in clinical risk,
and research needs to further examine the extent to which
the adverse effect of psychosocial factors on the incidence and
progression of heart disease is dependent on age.
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